Compugen Ltd (NAS:CGEN)
$ 1.595 -0.14 (-8.05%) Market Cap: 153.65 Mil Enterprise Value: 68.35 Mil PE Ratio: 0 PB Ratio: 2.50 GF Score: 53/100

Q2 2023 Compugen Ltd Earnings Call Transcript

Aug 07, 2023 / 12:30PM GMT
Release Date Price: $1.03 (-8.04%)
Operator

Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's second quarter 2023 results conference call. (Operator Instructions) As a reminder, today's call is being recorded. An audio webcast of this call will be made available on the Investors section of Compugen's website, www.cgen.com. I would now like to introduce Yvonne Naughton, Head of Investor Relations and Corporate Communications. Yvonne, please go ahead.

Yvonne Naughton
Compugen Ltd. - Head of IR & Corporate Communications

Thank you, operator, and thank you all for joining us on the call today. Joining me for Compugen for the prepared remarks are Dr. Anat Cohen-Dayag, President and Chief Executive Officer; and Alberto Sessa, Chief Financial Officer. Dr. Henry Adewoye, Chief Medical Officer; and Dr. Eran Ophir, Chief Scientific Officer, will join us for the Q&A.

Before we begin, I would like to remind you that during this call, the company may make projections or forward-looking statements regarding future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot